Medicine
Nalmefene 2 mg/2 mL injection
Nalmefene 2 mg/2 mL injection is a generic prescription medicine for intramuscular, intravenous, subcutaneous use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Store in original carton. Protect from…
Key facts
- Active ingredient (INN)
- Nalmefene
- Brand
- Sold under the generic name
- Strength
- 2 mg/2 mL
- Dosage form
- Injection
- Route
- Intramuscular, intravenous, subcutaneous
- Packs
- 1 vial of 2 mL, 10 vials of 2 mL
- Manufacturers
- Chengdu Shuode PharmaceuticalKnoa Pharma
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Store in original carton. Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N07BB05 Nalmefene
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 February 2022
- Identifiers
- RxCUI 2592953, 2672926DailyMed set ID 3abfbffc-9e52-4fc6-ae92-6e0a97f4afe7, 22d67228-6c24-47ca-afc7-52ef279520a0NDC 59011-960, 82432-102Application ANDA212955, ANDA216007
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, glass in 1 carton / 2 mL in 1 vial, glass | 82432-102-02 | Chengdu Shuode Pharmaceutical | 15 November 2023 |
| 10 vial, glass in 1 carton / 2 mL in 1 vial, glass | 59011-960-10 | Knoa Pharma | 8 February 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Nalmefene
Clinical summary
Nalmefene is an opioid antagonist indicated for the emergency treatment of known or suspected overdose induced by natural or synthetic opioids in adults and pediatric patients aged 12 years and older, among other approved uses. MedsAcross supplies Nalmefene for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NalmefeneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- OPVEE prescribing information (Indivior) · U.S. National Library of Medicine, DailyMed
- Selincro: European public assessment report (EPAR) · European Medicines Agency
Need Nalmefene 2 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.